医学
黑色素瘤
肿瘤科
内科学
肿瘤浸润淋巴细胞
队列
生物标志物
免疫疗法
转移性黑色素瘤
队列研究
梅德林
癌症
总体生存率
前瞻性队列研究
癌症研究
作者
Mark Schuiveling,Isabella A.J. van Duin,Laurens S. ter Maat,J. C. van der Weerd,Rik J. Verheijden,Franchette van den Berkmortel,Christian U. Blank,Gerben E. Breimer,Femke Burgers,Marye J. Boers‐Sonderen,Alfons J.M. van den Eertwegh,Jan Willem B. de Groot,John B.A.G. Haanen,Geke A.P. Hospers,Ellen Kapiteijn,Djura Piersma,Gerard Vreugdenhil,Hans M. Westgeest,Anne M.R. Schrader,Josien P. W. Pluim
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2025-10-16
卷期号:11 (12): 1470-1470
被引量:2
标识
DOI:10.1001/jamaoncol.2025.4072
摘要
In this cohort study, among patients with advanced melanoma, higher levels of AI-detected TILs on pretreatment hematoxylin-eosin slides were independently associated with improved ICI response and survival. Given the accessibility of TIL scoring on routine histology, TILs may serve as a biomarker for ICI outcomes. To facilitate broader validation, the Hover-NeXt architecture and model weights are publicly available.
科研通智能强力驱动
Strongly Powered by AbleSci AI